The interaction between BDNF and DRD2 in Bipolar II disorder but not in bipolar I disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 159 B, Issue 5, 2012, Pages 501-507

  Huang, Chih Chun ^a   Chang, Yun Hsuan ^b   Lee, Sheng Yu ^a,b   Chen, Shiou Lan ^b   Chen, Shih Heng ^b   Chu, Chun Hsien ^b   Huang, San Yuan ^c   Tzeng, Nian Sheng ^c   Lee, I Hui ^a,b   Yeh, Tzung Lieh ^a,b   Yang, Yen Kuang ^a,b   Lu, Ru Band ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

BDNF; Bipolar disorders; DRD2 ANKK1; Genetic interaction

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 2 RECEPTOR;

ADULT; ANKK1 GENE; ARTICLE; BDNF GENE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CONTROLLED STUDY; DNA POLYMORPHISM; DRD2 GENE; GENE; GENE INTERACTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D2;

EID: 84861920886     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32055     Document Type: Article

References (75)

1. Akiskal HS. 1995. The bipolar spectrum: Research and clinical perspectives. Encephale 21(6): 3-11.
2. Akiskal HS. 2003. Validating 'hard' and 'soft' phenotypes within the bipolar spectrum: Continuity or discontinuity? J Affect Disord 73(1-2): 1-5.
3. Akiskal HS, Pinto O. 1999. The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am 22(3): 517-534 vii.
4. Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK. 1977. Cyclothymic disorder: Validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 134(11): 1227-1233.
5. Akiskal HS, Rosenthal RH, Rosenthal TL, Kashgarian M, Khani MK, Puzantian VR. 1979. Differentiation of primary affective illness from situational, symptomatic, and secondary depressions. Arch Gen Psychiatry 36(6): 635-643.
6. American Psychiatric Association, 2000. Diagnostic and statistical manual of mental disorders, text revision (DSM-IV-TR), 4th edition. Washington, DC: American Psychiatric Association.
7. Angst J. 1998. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 50(2-3): 143-151.
8. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W. 2003. Toward a re-definition of subthreshold bipolarity: Epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 73(1-2): 133-146.
9. Baquet ZC, Bickford PC, Jones KR. 2005. Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci 25(26): 6251-6259.
10. Benazzi F. 2001. Is 4 days the minimum duration of hypomania in bipolar II disorder? Eur Arch Psychiatry Clin Neurosci 251(1): 32-34.
11. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, et al. 2006. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311(5762): 864-868.
12. Beyer JL, Krishnan KR. 2002. Volumetric brain imaging findings in mood disorders. Bipolar Disord 4(2): 89-104.
13. Bocchetta A, Piccardi MP, Palmas MA, Chillotti C, Oi A, Del Zompo M. 1999. Family-based association study between bipolar disorder and DRD2, DRD4, DAT, and SERT in Sardinia. Am J Med Genet 88(5): 522-526.
14. Bocchio-Chiavetto L, Zanardini R, Bortolomasi M, Abate M, Segala M, Giacopuzzi M, Riva MA, Marchina E, Pasqualetti P, Perez J, et al. 2006. Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharmacol 16(8): 620-624.
15. Brugue E, Vieta E. 2007. Atypical antipsychotics in bipolar depression: Neurobiological basis and clinical implications. Prog Neuropsychopharmacol Biol Psychiatry 31(1): 275-282.
16. Buchner A, Faul F, Erdfelder E. 1996. G-power: A priori, post hoc, and compromise power analyses for the macintosh, Version 2.1.1. Trier, Germany: University of Trier.
17. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. 2004. Mapping complex disease loci in whole-genome association studies. Nature 429(6990): 446-452.
18. Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, Lee FS. 2004. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24(18): 4401-4411.
19. Chen ZY, Ieraci A, Teng H, Dall H, Meng CX, Herrera DG, Nykjaer A, Hempstead BL, Lee FS. 2005. Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. J Neurosci 25(26): 6156-6166.
20. Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC, Wilson B, Lu RB, Gean PW, Chuang DM, et al. 2006a. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 11(12): 1116-1125.
21. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, et al. 2006b. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314(5796): 140-143.
22. Coryell W, Endicott J, Reich T, Andreasen N, Keller M. 1984. A family study of bipolar II disorder. Br J Psychiatry 145: 49-54.
23. Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS. 1995. Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry 152(3): 385-390.
24. Craddock N, Sklar P. 2009. Genetics of bipolar disorder: Successful start to a long journey. Trends Genet 25(2): 99-105.
25. Drevets WC. 2000. Neuroimaging studies of mood disorders. Biol Psychiatry 48(8): 813-829.
26. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386(6627): 824-827.
27. Duman RS. 1998. Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 44(5): 324-335.
28. Duman RS. 2002. Synaptic plasticity and mood disorders. Mol Psychiatry 7( Suppl. 1): S29-S34.
29. Dunlop BW, Nemeroff CB. 2007. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64(3): 327-337.
30. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, et al. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112(2): 257-269.
31. Endicott J, Spitzer RL. 1978. A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35: 837-844.
32. Faul F, Erdfelder E, Buchner A, Lang AG. 2009. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods 41(4): 1149-1160.
33. Frustaci A, Pozzi G, Gianfagna F, Manzoli L, Boccia S. 2008. Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 58(3-4): 163-170.
34. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. 2001. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 158(1): 100-106.
35. Furlong RA, Coleman TA, Ho L, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC. 1998. No association of a functional polymorphism in the dopamine D2 receptor promoter region with bipolar or unipolar affective disorders. Am J Med Genet 81(5): 385-387.
36. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook EH Jr. 2004. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 161(9): 1698-1700.
37. Gershon AA, Vishne T, Grunhaus L. 2007. Dopamine D2-like receptors and the antidepressant response. Biol Psychiatry 61(2): 145-153.
38. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ. 2003. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 48(4): 186-189.
39. Huang SY, Lin WW, Ko HC, Lee JF, Wang TJ, Chou YH, Yin SJ, Lu RB. 2004. Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res 28(3): 374-384.
40. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, Harris CR, Marini AM, Enoch MA, Lipsky RH. 2005. BDNF variation and mood disorders: A novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30(7): 1353-1361.
41. Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P, Sedvall GC. 1999. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4(3): 290-296.
42. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB. 2003a. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60(3): 261-269.
43. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Maser J, Rice JA, Solomon DA, Keller MB. 2003b. The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: A clinical spectrum or distinct disorders? J Affect Disord 73(1-2): 19-32.
44. Keck PE Jr, McElroy SL, Arnold LM. 2001. Bipolar disorder. Med Clin North Am 85(3): 645-661 ix.
45. Kelsoe JR. 2003. Arguments for the genetic basis of the bipolar spectrum. J Affect Disord 73(1-2): 183-197.
46. Kirov G, Jones I, McCandless F, Craddock N, Owen MJ. 1999. Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5. Mol Psychiatry 4(6): 558-565.
47. Lee SY, Chen SL, Chang YH, Chen SH, Chu CH, Huang SY, Tzeng NS, Wang CL, Lee IH, Yeh TL, et al. 2010. The ALDH2 and DRD2/ANKK1 genes interacted in bipolar II but not bipolar I disorder. Pharmacogenet Genomics 20(8): 500-506.
48. Leszczynska-Rodziewicz A, Hauser J, Dmitrzak-Weglarz M, Skibinka M, Czerski P, Zakrzewska A, Kosmowska M, Rybakowski JK. 2005. Lack of association between polymorphisms of dopamine receptors, type D2, and bipolar affective illness in a Polish population. Med Sci Monit 11(6): CR289-295.
49. Li T, Liu X, Sham PC, Aitchison KJ, Cai G, Arranz MJ, Deng H, Liu J, Kirov G, Murray RM, et al. 1999. Association analysis between dopamine receptor genes and bipolar affective disorder. Psychiatry Res 86(3): 193-201.
50. Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH. 2005. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet Part B Neuropsychiatr Genet 139B(1): 51-53.
51. Lu RB, Lee JF, Huang SY, Lee SY, Chang YH, Kuo PH, Chen SL, Chen SH, Chu CH, Lin WW, et al. 2010. Interaction between ALDH2*1*1 and DRD2/ANKK1 TaqI A1A1 genes may be associated with antisocial personality disorder not co-morbid with alcoholism. Addict Biol DOI: 10.1111/j.1369-1600.2010.00268.x.
52. Machado-Vieira R, Dietrich MO, Leke R, Cereser VH, Zanatto V, Kapczinski F, Souza DO, Portela LV, Gentil V. 2007. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry 61(2): 142-144.
53. McMahon FJ, Simpson SG, McInnis MG, Badner JA, MacKinnon DF, DePaulo JR. 2001. Linkage of bipolar disorder to chromosome 18q and the validity of bipolar II disorder. Arch Gen Psychiatry 58(11): 1025-1031.
54. Montag C, Markett S, Basten U, Stelzel C, Fiebach C, Canli T, Reuter M. 2010. Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met polymorphism impacts novelty seeking and harm avoidance. Neuropsychopharmacology 35(9): 1860-1867.
55. Nakata K, Ujike H, Sakai A, Uchida N, Nomura A, Imamura T, Katsu T, Tanaka Y, Hamamura T, Kuroda S. 2003. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 337(1): 17-20.
56. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. 2002. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: Evidence from a family-based association study. Am J Hum Genet 71(3): 651-655.
57. Novak G, LeBlanc M, Zai C, Shaikh S, Renou J, DeLuca V, Bulgin N, Kennedy JL, Le Foll B. 2010. Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann Hum Genet 74(4): 291-298.
58. Osby U, Brandt L, Correia N, Ekbom A, Sparen P. 2001. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 58(9): 844-850.
59. Pallanti S, Quercioli L, Pazzagli A, Rossi A, Dell'Osso L, Pini S, Cassano GB. 1999. Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder. Am J Psychiatry 156(7): 1094-1096.
60. Peng GS, Li G, Tzeng NS, Chen PS, Chuang DM, Hsu YD, Yang S, Hong JS. 2005. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: Role of microglia. Brain Res Mol Brain Res 134(1): 162-169.
61. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, Syvalahti EK, Hietala J. 1998. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3(3): 256-260.
62. Rihmer Z, Angst J. 2005. Mood disorders: Epidemiology. In: Sadock Ka, editor. Comprehensive textbook of psychiatry, 8th edition. Philadelphia, PA: Lippincott Williams & Wilkins. pp 1575-1582.
63. Ritchie T, Noble EP. 2003. Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res 28(1): 73-82.
64. Sadovnick AD, Remick RA, Lam R, Zis AP, Yee IM, Huggins MJ, Baird PA. 1994. Mood disorder service genetic database: Morbidity risks for mood disorders in 3, 942 first-degree relatives of 671 index cases with single depression, recurrent depression, bipolar I, or bipolar II. Am J Med Genet 54(2): 132-140.
65. Shimizu E, Hashimoto K, Iyo M. 2004. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits. Am J Med Genet Part B Neuropsychiatr Genet 126B(1): 122-123.
66. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, et al. 2002. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 7(6): 579-593.
67. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. 1990. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347(6289): 146-151.
68. Souery D, Lipp O, Mahieu B, Mendelbaum K, De Martelaer V, Van Broeckhoven C, Mendlewicz J. 1996. Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes. Am J Med Genet 67(6): 551-555.
69. Stober G, Jatzke S, Heils A, Jungkunz G, Knapp M, Mossner R, Riederer P, Lesch KP. 1998. Insertion/deletion variant (-141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: Lack of association with schizophrenia and bipolar affective disorder. Short communication. J Neural Transm 105(1): 101-109.
70. Stoll AL, Renshaw PF, Yurgelun-Todd DA, Cohen BM. 2000. Neuroimaging in bipolar disorder: What have we learned? Biol Psychiatry 48(6): 505-517.
71. Tang J, Xiao L, Shu C, Wang G, Liu Z, Wang X, Wang H, Bai X. 2008. Association of the brain-derived neurotrophic factor gene and bipolar disorder with early age of onset in mainland China. Neurosci Lett 433(2): 98-102.
72. Urata T, Takahashi N, Hakamata Y, Iijima Y, Kuwahara N, Ozaki N, Ono Y, Amano M, Inada T. 2007. Gene-gene interaction analysis of personality traits in a Japanese population using an electrochemical DNA array chip analysis. Neurosci Lett 414(3): 209-212.
73. Vieta E, Gasto C, Otero A, Nieto E, Vallejo J. 1997. Differential features between bipolar I and bipolar II disorder. Compr Psychiatry 38(2): 98-101.
74. Xu J, Liu Y, Wang P, Li S, Wang Y, Li J, Zhou D, Chen Z, Zhao T, Wang T, et al. 2010. Positive association between the brain-derived neurotrophic factor (BDNF) gene and bipolar disorder in the Han Chinese population. Am J Med Genet Part B Neuropsychiatr Genet 153B(1): 275-279.
75. Zhan L, Kerr JR, Lafuente MJ, Maclean A, Chibalina MV, Liu B, Burke B, Bevan S, Nasir J. 2011. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder. Neuropathol Appl Neurobiol 37(2): 206-219.